APP and Cognitive impairment: The mouse model APP/PS1ΔE9 that expresses APP with the Swedish mutation and mutant human PSEN1 with a deletion of exon 9 shows formation of amyloid plaques prior to typical cognitive impairments [8,9], is used to examine pathophysiological events associated to preclinical AD [10].